Biomarkers have supplemented clinical findings and imaging in the diagnosis, prognosis and management of rheumatoid arthritis (RA) for decades: rheumatoid factor was first described more than 75 years ago, in 1939. Today there are hopes that biomarkers will also prove valuable in guiding the selection of the most effective biologic agents for individual patients, replacing ...
Are biomarkers the next step forward in RA?
Sponsored by Bristol-Myers Squibb Australia.
2 years ago